---
title: "Economic analysis supports cost-effectiveness of Guardian monitoring system in high-risk acute coronary syndromes"
date: "2025-02-14T15:44:13.000Z"
publishedDate: "14 février 2025"
summary: "Avertix Medical has announced the publication of new data on the cost-effectiveness of its Guardian system in high-risk acute coronary syndrome (ACS) patients. The Guardian system is a US Food and Drug Administration (FDA)-approved heart attack warning system to improve long-term management and outcomes of high-risk coronary disease."
importance: ""
sourceUrl: "https://cardiovascularnews.com/economic-analysis-supports-cost-effectiveness-of-guardian-monitoring-system-in-high-risk-acute-coronary-syndromes/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-02-14-economic-analysis-supports-cost-effectiveness-of-guardian-monitoring-system-in-high-risk-acute-coronary-syndromes"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/06/AMSG3E-guardian-logo.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/economic-analysis-supports-cost-effectiveness-of-guardian-monitoring-system-in-high-risk-acute-coronary-syndromes/"
---

![Economic analysis supports cost-effectiveness of Guardian monitoring system in high-risk acute coronary syndromes](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/06/AMSG3E-guardian-logo.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/economic-analysis-supports-cost-effectiveness-of-guardian-monitoring-system-in-high-risk-acute-coronary-syndromes/*

## L’essentiel

Avertix Medical has announced the publication of new data on the cost-effectiveness of its Guardian system in high-risk acute coronary syndrome (ACS) patients. The Guardian system is a US Food and Drug Administration (FDA)-approved heart attack warning system to improve long-term management and outcomes of high-risk coronary disease.

## Lien source

https://cardiovascularnews.com/economic-analysis-supports-cost-effectiveness-of-guardian-monitoring-system-in-high-risk-acute-coronary-syndromes/
